214 related articles for article (PubMed ID: 36354249)
1. Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients.
Contreras G; Ho D
Curr Opin Organ Transplant; 2022 Aug; 27(4):243-249. PubMed ID: 36354249
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
[TBL] [Abstract][Full Text] [Related]
3. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
Bruminhent J; Rotjanapan P; Watcharananan SP
Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation.
Grossi PA; Kamar N; Saliba F; Baldanti F; Aguado JM; Gottlieb J; Banas B; Potena L
Transpl Int; 2022; 35():10332. PubMed ID: 35812158
[TBL] [Abstract][Full Text] [Related]
6. The next frontier: cytomegalovirus antiviral stewardship programs in solid organ transplant.
Kleiboeker HL; Saddler CM; Jorgenson MR
Curr Opin Infect Dis; 2023 Dec; 36(6):497-504. PubMed ID: 37815319
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Razonable RR; Humar A
Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease.
Karaba AH; Figueroa A; Werbel WA; Dioverti MV; Steinke SM; Ray SC; Cox AL; Avery RK
Transpl Infect Dis; 2021 Aug; 23(4):e13682. PubMed ID: 34216086
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients.
Poirier-Toulemonde AS; Milpied N; Cantarovich D; Morcet JF; Billaudel S; Imbert-Marcille BM
J Clin Microbiol; 2000 Sep; 38(9):3143-9. PubMed ID: 10970347
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature.
Scherger S; Mathur S; Bajrovic V; Johnson SC; Benamu E; Ramanan P; Wolfel G; Levi ME; Abidi MZ
Transpl Infect Dis; 2020 Jun; 22(3):e13282. PubMed ID: 32232951
[TBL] [Abstract][Full Text] [Related]
14. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients.
Wang N; Athans V; Neuner E; Bollinger J; Spinner M; Brizendine K
Transpl Infect Dis; 2018 Dec; 20(6):e12991. PubMed ID: 30184302
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.
Benmarzouk-Hidalgo OJ; Cordero E; Martín-Peña A; García-Prado E; Gentil MA; Gomez-Bravo MA; Barrera-Pulido L; Cisneros JM; Perez-Romero P
Antivir Ther; 2009; 14(5):641-7. PubMed ID: 19704166
[TBL] [Abstract][Full Text] [Related]
16. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients.
Koval CE
Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
Kusne S; Shapiro R; Fung J
Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
[TBL] [Abstract][Full Text] [Related]
18. Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.
Limaye AP; Babu TM; Boeckh M
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33115722
[TBL] [Abstract][Full Text] [Related]
19. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
[TBL] [Abstract][Full Text] [Related]
20. CMV infection and management among pediatric solid organ transplant recipients.
Downes KJ; Sharova A; Boge CLK; Vader D; Mitrou M; Hayes M; Galetaki DM; Gianchetti L; Vella LA; Li Y
Pediatr Transplant; 2022 May; 26(3):e14220. PubMed ID: 34994041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
